InvestorsHub Logo
Followers 52
Posts 1915
Boards Moderated 0
Alias Born 04/17/2015

Re: None

Thursday, 06/01/2017 2:16:59 PM

Thursday, June 01, 2017 2:16:59 PM

Post# of 102774
NCC enters into a letter of intent to buy BluDog Products LLC

Jun 01, 2017
OTC Disclosure & News Service

-

INCC enters into a letter of intent to buy BluDog Products LLC

PR Newswire

SARASOTA, Fla., June 1, 2017

SARASOTA, Fla., June 1, 2017 /PRNewswire/ -- International Consolidated Companies Inc., (OTC:INCC), has entered into a letter of intent to acquire CBD product developer BluDog Products LLC.

BluDog Products is strategically introducing a water soluble CBD oil superfood and energy drinks (with an extended release formulation) which are easily absorbed. Using a licensed, patented CBD delivery system BluDog's CBD products are an alternative over-the-counter therapeutic option to help relieve post-sports in?ammation as well as promote relaxation and well-being. BluDog's CBD products interact naturally with the body's anti-in?ammatory system without any known side e?ects.

BDP is tapping into a multi-billion dollar market for e?ective, non-addictive and non-opioid pain relief products that have no known side e?ects. With the demand for pain solutions, many prescribed products have come under scrutiny. Prescription drug abuse is currently the nation's fastest growing drug addiction.*

According to the American Pain Society, pain is the most common symptom that causes people to seek medical care. The global market for pain management by revenue at manufacturers' sales levels is projected to grow from $33.6 billion in 2014 to nearly $34.8 billion in 2015, and $41.3 billion in 2020, with a compound annual growth rate (CAGR) of 3.2% between 2015 and 2020. U.S. sales account for approximately 48% of all of these sales. BDP is focusing on the over-the- counter segment of this market.**

The Problem

Pain and in?ammation are chronic issues that plague an active and aging population. Pain has been medicated the same way for 40 years using over-the- counter pain relief products or prescription opioids. This consumer category has very few alternative solutions, creating a tremendous opportunity for innovative, ethical, quality and e?ective solutions.

The Solution

BluDog has developed proprietary, innovative CBD products to ful?ll the demand in the burgeoning pain relief market. There is a lack of e?ective, non-addictive pain relief products creating a huge void and demand for safe innovative treatments which BluDog seeks to fill.

www.bludogproducts.com https://www.facebook.com/BluDogProducts/

Competition

The competition in the water-soluble CBD category is very limited. There are only a few companies that sell water-soluble CBD and their product o?erings include only one or two items, which are liquid based. BluDog o?ers a proprietary water-soluble CBD solution with an extended release formulation providing relief on a consistent level over time. BluDog intends to o?er a variety of ingestible and topical products, as well as a balm.